NICLF yields 1694.92% · MRK yields 2.76%● Live data
📍 NICLF pulled ahead of the other in Year 1
Combined, NICLF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NICLF + MRK for your $10,000?
Class 1 Nickel and Technologies Limited engages in the exploration and development of minerals and base metals in Canada. The company explores for nickel, copper, and cobalt sulphide deposits. It primarily holds a 100% interest in the Alexo-Dundonald project, comprising 95 Boundary Cell Mining Claims, Single Cell Mining Claims, Leased Claims, and Patented Claims, which covers an approximately 1,895 hectares located to the northeast of Timmins, Ontario. It also holds option to acquire 100% interest in the Somanike Project located in the Abitibi Region of Quebec, and 100% interest in the River Valley PGE Project located to northeastern Ontario, Canada. The company was formerly known as Legendary Ore Mining Corporation and changed its name to Class 1 Nickel and Technologies Limited in September 2019. Class 1 Nickel and Technologies Limited was incorporated in 1989 and is headquartered in Toronto, Canada.
Full NICLF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.